(1) The Department of Corrections shall adopt rules to implement and enforce the program of hormone or antiandrogen, such as medroxyprogesterone acetate, treatment under ORS 144.625. Rules adopted under this subsection shall include, but not be limited to:
(a) A requirement that the offender be informed of the effect of the treatment program, including any side effects that may result from the treatment program;
(b) A requirement that the offender acknowledge receipt of the information the department is required to present to the offender under paragraph (a) of this subsection;
(c) Procedures to monitor compliance with the treatment program; and
(d) Procedures to test for attempts to counteract the treatment program that may include chemical testing of the offender’s blood and urine.
(2) A supervisory authority defined under ORS 144.087 may contract with community physicians, laboratories or other medical service providers to administer the program of hormone or antiandrogen treatment under ORS 144.625 or to monitor compliance with the treatment program. [1999 c.435 §2]
Note: See note under 144.625.
Section: Previous 144.610 144.613 144.615 144.617 144.620 144.622 144.625 144.627 144.629 144.631 144.635 144.637 144.639 144.640 144.641 NextLast modified: August 7, 2008